3.49
price down icon4.12%   -0.15
pre-market  Vorhandelsmarkt:  3.31   -0.18   -5.16%
loading

Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten

pulisher
May 01, 2025

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

BlackRock, Inc. Reduces Stake in Voyager Therapeutics Inc - GuruFocus

Apr 30, 2025
pulisher
Apr 29, 2025

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annua - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting | VYGR Stock News - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Voyager Therapeutics Presents New Data on Tau Silencing Gene Therapy VY1706 and Anti-Amyloid Gene Therapy at ASGCT Annual Meeting - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Revolutionary Alzheimer's Gene Therapy Achieves 73% Tau Reduction: Voyager's Breakthrough Data Revealed - Stock Titan

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 27, 2025

JPMorgan Chase & Co. Decreases Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Geode Capital Management LLC Grows Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 26, 2025
pulisher
Apr 21, 2025

Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... - Yahoo Finance

Apr 21, 2025
pulisher
Apr 21, 2025

Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and Promising Pipeline Developments - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Apr 21, 2025
pulisher
Apr 19, 2025

Franklin Resources Inc. Reduces Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Vanguard Group Inc. Grows Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 17, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Boosts Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Has $696,000 Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Voyager Therapeutics stock hits 52-week low at $2.81 - Investing.com

Apr 10, 2025
pulisher
Apr 09, 2025

Voyager Therapeutics stock hits 52-week low at $2.81 By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Institutional investors may adopt severe steps after Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) latest 15% drop adds to a year losses - simplywall.st

Apr 09, 2025
pulisher
Apr 08, 2025

7 Analysts Assess Voyager Therapeutics: What You Need To Know - Benzinga

Apr 08, 2025
pulisher
Apr 05, 2025

Voyager Therapeutics chief medical officer sells $34,594 in stock By Investing.com - Investing.com India

Apr 05, 2025
pulisher
Apr 04, 2025

Top Executives Unload Thousands of Voyager Therapeutics Shares! - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

Voyager Therapeutics chief medical officer sells $34,594 in stock - Investing.com

Apr 04, 2025
pulisher
Mar 31, 2025

Voyager Therapeutics stock hits 52-week low at $3.54 By Investing.com - Investing.com Philippines

Mar 31, 2025
pulisher
Mar 31, 2025

Voyager reveals promising Alzheimer’s therapy data By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Voyager Therapeutics stock hits 52-week low at $3.54 - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Voyager Therapeutics Presents Promising Tau-Targeting Gene Therapy And Antibody Data At AD/PD 2025 - Nasdaq

Mar 31, 2025
pulisher
Mar 31, 2025

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025 - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Voyager reveals promising Alzheimer’s therapy data - Investing.com

Mar 31, 2025
pulisher
Mar 20, 2025

Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, - GlobeNewswire

Mar 20, 2025
pulisher
Mar 19, 2025

Voyager Therapeutics at Virtual CNS Forum: Strategic Insights on Neurotherapeutics - Investing.com UK

Mar 19, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc.VYGR - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Labcorp Holdings (LH) and Arcutis Biotherapeutics (ARQT) - The Globe and Mail

Mar 17, 2025
pulisher
Mar 15, 2025

Canaccord Genuity Group Cuts Voyager Therapeutics (NASDAQ:VYGR) Price Target to $12.00 - Armenian Reporter

Mar 15, 2025
pulisher
Mar 15, 2025

Voyager Therapeutics (NASDAQ:VYGR) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

Voyager Therapeutics COO Robin Swartz sells $30,927 in stock - MSN

Mar 14, 2025
pulisher
Mar 14, 2025

Cantor Fitzgerald Reaffirms “Overweight” Rating for Voyager Therapeutics (NASDAQ:VYGR) - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 13, 2025
pulisher
Mar 13, 2025

H.C. Wainwright maintains $30 target on Voyager Therapeutics stock By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics’ Earnings Call Highlights Promising Future - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics stock hits 52-week low at $3.67 - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics stock hits 52-week low at $3.67 By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics price target lowered to $10 from $12 at Wells Fargo - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics Inc earnings missed by $0.22, revenue fell short of estimates - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Earnings call transcript: Voyager Therapeutics Q4 2024 sees stock dip post-earnings - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 12, 2025
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
Kapitalisierung:     |  Volumen (24h):